backJoin us for the sixteenth CLE webinar in our Fundamentals of EU Pharmaceutical Law series.
This session will cover Transparency in the Pharmaceutical Sector, an area that has undergone profound evolution over the past decades and continues to generate significant litigation and policy debate. The session will mainly explore transparency of clinical trial data, including public access rules and the protection of commercially confidential information, as well as the EMA access-to-documents regime and transparency of regulatory documents. We will also discuss the broader policy trend toward increased procedural openness.
This webinar will provide participants with practical insights into the evolving balance between regulatory transparency, public health objectives and the protection of industry interests — a balance that increasingly shapes regulatory strategy and risk management in the EU.
For question, or for information about registration, contact Sydney Forte.